"Poliovirus Vaccine, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
Descriptor ID |
D011055
|
MeSH Number(s) |
D20.215.894.899.623.750
|
Concept/Terms |
Poliovirus Vaccine, Oral- Poliovirus Vaccine, Oral
- Oral Poliovirus Vaccine
- Vaccine, Oral Poliovirus
- Sabin Vaccine
- Vaccine, Sabin
|
Below are MeSH descriptors whose meaning is more general than "Poliovirus Vaccine, Oral".
Below are MeSH descriptors whose meaning is more specific than "Poliovirus Vaccine, Oral".
This graph shows the total number of publications written about "Poliovirus Vaccine, Oral" by people in this website by year, and whether "Poliovirus Vaccine, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Poliovirus Vaccine, Oral" by people in Profiles.
-
Going Viral! Unraveling the Impact of Nonpolio Enteroviruses on Oral Vaccine Responses. J Infect Dis. 2019 04 08; 219(8):1173-1175.
-
SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines. J Infect. 2019 06; 78(6):476-483.
-
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA. 1996 Jun 05; 275(21):1639-45.
-
Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine. Am J Epidemiol. 1969 Aug; 90(2):146-56.
-
Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine. Am J Dis Child. 1969 Feb; 117(2):161-8.
-
Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol. 1966 Mar; 83(2):224-37.